Diagnos Inc New (DGNOF) 0.0375 $DGNOF
IIROC Trade Resumption - Diagnos Inc.
Newsfile Corp - 1 hr 11 mins ago
Trading resumes in:
IIROC Trading Resumption - ADK
CNW Group - 1 hr 11 mins ago
Trading resumes in:
DIAGNOS Announces Major Strategic Alliance in Latin America for a Contract of $1.38 M USD
Marketwired - 1 hr 20 mins ago
BROSSARD, QUEBEC--(Marketwired - Jun 8, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE:ADK), an innovative leader in healthcare technical services, including screening software and algorithm development, data analysis, and image processing, announces today a contract award for a strategic initiative in Latin America to screen a large population of diabetics by December 31, 2016. Under the final agreement, it is expected that DIAGNOS will receive a 40% deposit on the total amount and a monthly payment until December 31, 2016. DIAGNOS is working closely with the customer to identify the requirements for an additional two years of services.
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Short Term Financing
Marketwire Canada - Tue Jun 07, 2:55PM CDT
BROSSARD, QUEBEC--(Marketwired - Jun 7, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces $150,000 financing in the form of short term debt and bonus share warrants.
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Changes to its Board of Directors
Marketwired - Fri May 20, 12:29PM CDT
BROSSARD, QUEBEC--(Marketwired - May 20, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce, effective immediately, the appointment of Mr. Tristam Coffin and Mr. Jean-Yves Thérien as directors of the Corporation.
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces an Update following Closing of Private Placement
Marketwire Canada - Wed May 18, 3:50PM CDT
BROSSARD, QUEBEC--(Marketwired - May 18, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces an update following the closing of a non-brokered private placement ("Private Placement" previously announced on May 3rd, 2016. The Private Placement now consists of 93 units for an aggregate value of $930,000, an increase of one unit and $10,000 over the amount of $920,000 previously announced on May 3rd, 2016.
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Closing of Private Placement
Marketwired - Tue May 03, 2:01PM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces the closing of a non-brokered private placement ("Private Placement" previously announced on April 7, 2016. The Private Placement consists of 92 units (each a "Unit" for an aggregate value of $920,000. Each Unit consists of:
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Private Placement
Marketwired - Thu Apr 07, 10:26AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces a private placement ("Private Placement" of up to $1,070,000 worth of units (each a "Unit". Each Unit consists of:
ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Non-Brokered Private Placement
Marketwired - Mon Jan 11, 4:04PM CST
DIAGNOS Inc. ("DIAGNOS" or "the Corporation" (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce its intention to complete a private placement offering ("Private Placement" of up to 30,000,000 units of the Corporation at $0.05 per unit (each a "Unit" for aggregate gross proceeds of up to $1,500,000. Each Unit will consist of one common share of the Corporation (each a "Common Share" and one half a Common Share purchase warrant (each, a "Warrant". Each whole Warrant will entitle its holder to purchase one additional Common Share at an exercise price of $0.08 for twelve (12) months from the closing date of the Private Placement. The Corporation may accelerate the expiry time of the Warrants if, at any time, the weighted average trading price of the Common shares of the Corporation listed on the TSX Venture Exchange (the "Exchange" is equal to or above $0.15 per share for a period of 20 consecutive trading days.
ADK.VN: 0.065 (+0.005)
IIROC Trade Resumption - Diagnos Inc.
Newsfile Corp - 1 hr 11 mins ago
Trading resumes in:
IIROC Trading Resumption - ADK
CNW Group - 1 hr 11 mins ago
Trading resumes in:
DIAGNOS Announces Major Strategic Alliance in Latin America for a Contract of $1.38 M USD
Marketwired - 1 hr 20 mins ago
BROSSARD, QUEBEC--(Marketwired - Jun 8, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE:ADK), an innovative leader in healthcare technical services, including screening software and algorithm development, data analysis, and image processing, announces today a contract award for a strategic initiative in Latin America to screen a large population of diabetics by December 31, 2016. Under the final agreement, it is expected that DIAGNOS will receive a 40% deposit on the total amount and a monthly payment until December 31, 2016. DIAGNOS is working closely with the customer to identify the requirements for an additional two years of services. ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Short Term Financing
Marketwire Canada - Tue Jun 07, 2:55PM CDT
BROSSARD, QUEBEC--(Marketwired - Jun 7, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces $150,000 financing in the form of short term debt and bonus share warrants. ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Changes to its Board of Directors
Marketwired - Fri May 20, 12:29PM CDT
BROSSARD, QUEBEC--(Marketwired - May 20, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce, effective immediately, the appointment of Mr. Tristam Coffin and Mr. Jean-Yves Thérien as directors of the Corporation. ADK.VN: 0.065 (+0.005)
DIAGNOS Announces an Update following Closing of Private Placement
Marketwire Canada - Wed May 18, 3:50PM CDT
BROSSARD, QUEBEC--(Marketwired - May 18, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces an update following the closing of a non-brokered private placement ("Private Placement" previously announced on May 3rd, 2016. The Private Placement now consists of 93 units for an aggregate value of $930,000, an increase of one unit and $10,000 over the amount of $920,000 previously announced on May 3rd, 2016. ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Closing of Private Placement
Marketwired - Tue May 03, 2:01PM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces the closing of a non-brokered private placement ("Private Placement" previously announced on April 7, 2016. The Private Placement consists of 92 units (each a "Unit" for an aggregate value of $920,000. Each Unit consists of: ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Private Placement
Marketwired - Thu Apr 07, 10:26AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces a private placement ("Private Placement" of up to $1,070,000 worth of units (each a "Unit". Each Unit consists of: ADK.VN: 0.065 (+0.005)
DIAGNOS Announces Non-Brokered Private Placement
Marketwired - Mon Jan 11, 4:04PM CST
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"
(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce its intention to complete a private placement offering ("Private Placement" of up to 30,000,000 units of the Corporation at $0.05 per unit (each a "Unit" for aggregate gross proceeds of up to $1,500,000. Each Unit will consist of one common share of the Corporation (each a "Common Share" and one half a Common Share purchase warrant (each, a "Warrant". Each whole Warrant will entitle its holder to purchase one additional Common Share at an exercise price of $0.08 for twelve (12) months from the closing date of the Private Placement. The Corporation may accelerate the expiry time of the Warrants if, at any time, the weighted average trading price of the Common shares of the Corporation listed on the TSX Venture Exchange (the "Exchange" is equal to or above $0.15 per share for a period of 20 consecutive trading days. ADK.VN: 0.065 (+0.005)
